Sort
23,748 grants matching “melanoma”
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes
$328,084Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2021 · CA
Impact of MC1R Functional Variants on the DNA Damage Response of Human Melanocyte
$328,017Zalfa Abdel-Malek · University Of Cincinnati · R01 · FY2010 · ES
Bioinformatics Core
$327,937Andrew V Kossenkov · Wistar Institute · U54 · FY2017 · CA
Linking Dynamics to Catalysis and Inhibition in ERK2
$327,886Natalie G Ahn · University Of Colorado · R01 · FY2017 · GM
Genetic Analysis of Convergent Extension in Zebrafish
$327,875Lilianna Solnica-Krezel · Vanderbilt University · R01 · FY2006 · GM
EGR2 in T cell tolerance
$327,850Thomas F Gajewski · University Of Chicago · R01 · FY2016 · CA
Host STING pathway in anti-tumor immunity
$327,850Thomas F Gajewski · University Of Chicago · R01 · FY2015 · CA
Host STING pathway in anti-tumor immunity
$327,850Thomas F Gajewski · University Of Chicago · R01 · FY2016 · CA
The Role of the PI3K-AKT Pathway in Melanoma Brain Metastasis
$327,850Michael Davies · University Of Tx Md Anderson Can Ctr · R01 · FY2011 · CA
Cyclic Dinucleotides in Combinatorial Immunotherapy for Cancer
$327,850Young J. Kim · Vanderbilt University Medical Center · R01 · FY2017 · CA
EGR2 in T cell tolerance
$327,850Thomas F Gajewski · University Of Chicago · R01 · FY2015 · CA
The Role of the PI3K-AKT Pathway in Melanoma Brain Metastasis
$327,850Michael Davies · University Of Tx Md Anderson Can Ctr · R01 · FY2015 · CA
EGR2 in T cell tolerance
$327,850Thomas F Gajewski · University Of Chicago · R01 · FY2012 · CA
The Role of the PI3K-AKT Pathway in Melanoma Brain Metastasis
$327,850Michael Davies · University Of Tx Md Anderson Can Ctr · R01 · FY2012 · CA
Host STING pathway in anti-tumor immunity
$327,850Thomas F Gajewski · University Of Chicago · R01 · FY2014 · CA
Linking Dynamics to Catalysis and Inhibition in ERK2
$327,820Natalie G Ahn · University Of Colorado · R01 · FY2016 · GM
In vivo real time detection of circulating melanoma cells
$327,807Vladimir P Zharov · Univ Of Arkansas For Med Scis · R01 · FY2015 · CA
Large heat shock proteins and their role in cancer therapy
$327,797John R. Subjeck · Roswell Park Cancer Institute Corp · R01 · FY2017 · CA
MPK -1 ERK SUBSTRATES AND THE CONTROL OF GERMLINE DEVELOPMENT
$327,745Tim B. Schedl · Washington University · R01 · FY2011 · GM
Combining targeted radionuclide therapy with a localized in situ vaccine to overcome immune suppression in the tumor microenvironment and augment T cell responses
$327,645Paul M Sondel · University Of Wisconsin-Madison · P01 · FY2021 · CA
PREDICTIVE AND THERAPEUTIC UTILITIES OF EPIGENETIC CHANGES IN CHROMATIN IN MELANO
$327,633Sherman Morton Weissman · Yale University · P50 · FY2007 · CA
PREDICTIVE AND THERAPEUTIC UTILITIES OF EPIGENETIC CHANGES IN CHROMATIN IN MELANO
$327,632Sherman Morton Weissman · Yale University · P50 · FY2010 · CA
PREDICTIVE AND THERAPEUTIC UTILITIES OF EPIGENETIC CHANGES IN CHROMATIN IN MELANO
$327,632Sherman Morton Weissman · Yale University · P50 · FY2009 · CA
Identification of small molecule inhibitors of USP15
$327,632Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2024 · TR
PREDICTIVE AND THERAPEUTIC UTILITIES OF EPIGENETIC CHANGES IN CHROMATIN IN MELANO
$327,632Sherman Morton Weissman · Yale University · P50 · FY2008 · CA